VerhaevenR.P., VisserT.J., DocterR., HennemannG., SchalekampM.Plasma thyroxine, 3,3′,5-triiodothyronine and 3,3′,5′-triiodothyronine during beta-adrenergic blockade in hyperthyroidism. J Clin Endocrinol Metab1977; 44: 1002–5.
2.
MurchisonL.E., BewsherP.D., ChestersM.I., FerrierW.R.Comparison of propranolol and practolol in the management of hyperthyroidism. Br J Clin Pharmacol1976; 3: 273–7.
3.
TheiladeP., HansenJ.M., SkovstedL.Propranolol influences serum T3 and reverse T3 in hyperthyroidism. Lancet1977; 2: 363.
4.
WiersingaW.M., TouberJ.L.The influence of beta-adrenoceptor blocking agents on plasma thyroxine and triiodothyronine. J Clin Endocrinol Metab1977; 45: 293–8.
5.
FaberJ., FriisT., KirkegaardC.Serum T4, T3, and reverse T3 during treatment with propranolol in hyperthyroidism, L-T4 treated myxedema, and in normal man. Horm Metab Res1979; 11: 34–6.
